1. Home
  2. SNDR vs AMRX Comparison

SNDR vs AMRX Comparison

Compare SNDR & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Schneider National Inc.

SNDR

Schneider National Inc.

HOLD

Current Price

$26.92

Market Cap

4.0B

Sector

Industrials

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$12.46

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNDR
AMRX
Founded
1935
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.8B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
SNDR
AMRX
Price
$26.92
$12.46
Analyst Decision
Buy
Buy
Analyst Count
14
4
Target Price
$25.71
$13.25
AVG Volume (30 Days)
1.0M
1.7M
Earning Date
01-29-2026
10-30-2025
Dividend Yield
1.41%
N/A
EPS Growth
0.60
N/A
EPS
0.64
0.02
Revenue
$5,613,800,000.00
$2,934,959,000.00
Revenue This Year
$10.31
$9.99
Revenue Next Year
$4.52
$6.67
P/E Ratio
$42.20
$758.81
Revenue Growth
5.46
9.50
52 Week Low
$20.11
$6.69
52 Week High
$31.84
$12.68

Technical Indicators

Market Signals
Indicator
SNDR
AMRX
Relative Strength Index (RSI) 76.03 62.54
Support Level $22.31 $12.12
Resistance Level $27.74 $12.43
Average True Range (ATR) 0.79 0.31
MACD 0.40 -0.04
Stochastic Oscillator 88.10 75.77

Price Performance

Historical Comparison
SNDR
AMRX

About SNDR Schneider National Inc.

Schneider National Inc is a provider of surface transportation and logistics solutions in North America. The Company offers truckload, intermodal, and logistics services to a diverse customer base throughout the continental United States, Canada, and Mexico. The company's segments include Truckload; Intermodal; Logistics and other. It generates maximum revenue from the Truckload segment.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: